Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ACLY antibody (pSer454)

This anti-ACLY antibody is a Rabbit Polyclonal antibody detecting ACLY in WB, ELISA and IHC. Suitable for Human.
Catalog No. ABIN2134269

Quick Overview for ACLY antibody (pSer454) (ABIN2134269)

Target

See all ACLY Antibodies
ACLY (ATP Citrate Lyase (ACLY))

Reactivity

  • 96
  • 35
  • 33
  • 9
  • 6
  • 6
  • 5
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
Human

Host

  • 85
  • 14
Rabbit

Clonality

  • 71
  • 28
Polyclonal

Conjugate

  • 53
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
This ACLY antibody is un-conjugated

Application

  • 81
  • 36
  • 27
  • 26
  • 19
  • 19
  • 18
  • 12
  • 11
  • 6
  • 6
  • 3
  • 3
  • 2
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
  • Binding Specificity

    • 19
    • 15
    • 7
    • 6
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer454

    Immunogen

    ATP Citrate Lyase antibody was raised in Rabbit using synthesized phosphopeptide derived from human ATP Citrate Lyase around the phosphorylation site of Ser454 as the immunogen

    Isotype

    IgG
  • Application Notes

    WB: 1:500-1:1000, IHC: 1:50-1:100, ELISA: 1:1000

    Restrictions

    For Research Use only
  • Concentration

    Lot specific

    Buffer

    PBS (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handling Advice

    Store at -20 °C for 1 year

    Storage

    -20 °C

    Storage Comment

    Store at -20 °C for 1 year
  • Target

    ACLY (ATP Citrate Lyase (ACLY))

    Alternative Name

    ATP Citrate Lyase

    Pathways

    Warburg Effect
You are here:
Chat with us!